Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|December 17, 2008
Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate geneSteven Lehrer, André Montazem, Lakshmi Ramanathan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2010
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancerRyan J Burri, Alice Y Ho, Kevin Forsythe, et al.
Brachytherapy|February 8, 2007
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancerAlice Y Ho, Ryan J Burri, Glenn T Jennings, et al.
Urologic Oncology|July 15, 2003
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) geneSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
Biomedicines|October 27, 2022
Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation TherapyKunal K Sindhu, Anthony D Nehlsen, Eric J Lehrer, et al.
Brachytherapy|October 25, 2016
American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancerDaniel E Spratt, Payal D Soni, Patrick W McLaughlin, et al.
Brachytherapy|January 22, 2020
Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapyKyrollis Attalla, Daniel Sagalovich, Kathryn E Marqueen, et al.
Urologic Oncology|January 1, 2023
Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancerChih Peng Chin, William H Smith, Jamie Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2007
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A Cesaretti, Richard G Stock, David P Atencio, et al.
Advances in Radiation Oncology|October 21, 2020
Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation TherapyKayla Collado, Sarah L Kerns, Michael A Diefenbach, et al.
Pageof 14